Dr Singh described India as the emerging global biotech destination and said that this is the most appropriate venue for such ...

For the quarter ended March 31, 2025, Edesa reported a net loss of $1.6 million, or $0.30 per common share, compared to a net ...

Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary ...

Nearly 600 attendees learned about life sciences industry trends and heard from 93 presenting biotechnology companies at ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

The University of California, Davis has announced two new strategic partnerships designed to strengthen its position as a ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.

Thai researchers have made an advancement by developing a rubber serum for medical use, showing potential in combating ...

Researchers are analyzing the bug oil’s bioactive properties, aiming to validate its safety and expand its promising ...

Having now appointed Henry Gosebruch as CEO of the intact company, Galapagos says its priorities are exploring strategic ...

Money flows out of Harvard into biotechs, housing projects, and retail storefronts. The school powers hospitals, tourism, and ...